Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 FY- Text added to 2023 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
advocacy, aforementioned, appeal, bid, biosimilar, bribery, campaign, CFO, CI, clearance, CMC, CODM, comparison, condensed, consecutive, COO, Craecker, cybersecurity, David, delisted, delisting, Denmark, departure, disaggregated, display, domestic, dossier, eleven, endorsement, enterprise, equating, EU, Evotec, filtering, Finland, footnote, Francoise, fullest, Gaza, grantee, ideally, inactive, inbound, inexpensive, joining, LS, MA, main, Maker, McGirr, omission, Organisation, overhauled, PDUFA, pecuniary, pharmacovigilance, Poland, Portugal, preemption, PTA, PTE, questionnaire, reconciling, regain, rescind, respiratory, revert, Robert, sanction, satisfactorily, slight, SM, SOC, sophisticated, sponsorship, subcommittee, tangible, textual, threat, tract, trailing, tranche, transitory, transposed, twenty, UK, unrealized, upper, vendor, waived, warehousing, younger
Removed:
acceleration, activating, allocate, allocation, antibody, ascribed, assist, bear, broaden, Bruton, bundle, calculating, Cambridge, carcinoma, cited, clear, CMS, combine, commented, comparative, conceal, concealing, constraint, contemplated, crystalline, defer, demonstration, dendritic, Derecognition, detailed, disabled, distinct, Distinguishing, elderly, electricity, Est, estate, evaluable, explore, extinguished, extinguishment, falsifying, freestanding, furniture, gap, glioblastoma, globally, GMP, Hedging, Hopitaux, hyperviscosity, IgM, inhibitor, initiative, insert, instance, kinase, La, LLS, lymphoma, lymphoproliferative, malignant, Mayne, melanoma, methodology, modification, molecule, negotiating, nondeductible, nonfinancial, overproduce, oversee, overstimulated, overstimulation, Parisien, partner, Ph, Pharma, plausible, predominantly, preempted, proliferation, promise, proportion, pursued, qualification, questioned, qui, ratio, real, rebate, reexamining, referral, reversal, reversed, reward, ruling, salt, satisfied, scheduled, separable, serum, shipment, society, SSP, standalone, suppressor, sweeping, tam, TME, transferring, Trousseau, tumor, tyrosine, unconstrained, unnecessary, untitled, updated, USDA, Washington, whistleblower, withholding, worse
Valuein 2022 FY filing- Value in 2023 FY filing
Original filings
Filing view